How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program
The U.S. Department of Health and Human Services unveiled 15 additional drugs chosen for the Medicare Drug Price Negotiation Program ...
The U.S. Department of Health and Human Services unveiled 15 additional drugs chosen for the Medicare Drug Price Negotiation Program ...
From the CMS document “Medicare Drug Price Negotiation Program: Selected Drugs for Initial PriceApplicability Year ...
An antibody drug is only as good as its ability to connect to its target. Sometimes a mutation at the ...
(Reuters) -Johnson & Johnson reported a first-quarter profit above Wall Street estimates on Tuesday, helped by strong sales of its ...
Wheel, a virtual care platform, has added three companies to its integrated virtual care ecosystem: prescription drug company Mark Cuban ...
A blockbuster Amgen antibody that treats bone conditions is set to face its first biosimilar competition. The FDA on Tuesday ...
That is the topic of a U.S. Senate hearing last week. One person testifying was ...
North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement ...
Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of ...
I just came across a nice overview article titled The financial ecosystem of pharmaceutical R&D. The white paper was developed ...
Copyright © 2024 The Israel Chronicle News.
The Israel Chronicle News is not responsible for the content of external sites.